Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.01.2025 | 187 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 20.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.01.2025ISIN NameAU000000CAI2 CALIDUS... ► Artikel lesen | |
14.01. | Nasdaq Stockholm AB: Delisting of Ziccum AB from Nasdaq First North Growth Market | 218 | GlobeNewswire | On January 10, 2025, Ziccum AB was declared bankrupt by Lund District Court.
According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist the financial... ► Artikel lesen | |
10.01. | XFRA 7IZ: AUSSETZUNG/SUSPENSION | 250 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZICCUM AB 7IZ SE0011415595... ► Artikel lesen | |
10.01. | Ziccum AB: Ziccum AB (publ) files for bankruptcy | 123 | GlobeNewswire (Europe) | The board of directors of Ziccum AB (publ) ("Ziccum"or the "Company") has today, 10 January 2025, resolved to file for bankruptcy on behalf of the Company to manage the financial situation that has... ► Artikel lesen | |
25.11.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Ziccum AB (publ) | 181 | GlobeNewswire | With effect from November 26, 2024, the unit rights in Ziccum AB (publ) will be
traded on First North Growth Market. Trading will continue up until and
including December 05, 2024.
Instrument: Unit... ► Artikel lesen | |
20.11.24 | Ziccum AB: Ziccum publishes prospectus due to upcoming rights issue | 124 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
20.11.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.11.2024 | 390 | Xetra Newsboard | Das Instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC ETF wird cum Kapitalmassnahme gehandelt am 20.11.2024 und ex Kapitalmassnahme am 21.11.2024 The instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC... ► Artikel lesen | |
29.10.24 | Ziccum AB: Ziccum AB (publ) Interim report Q3 2024 | 115 | GlobeNewswire (Europe) | INTERIM REPORT Q3, 1 JULY - 30 SEPTEMBER 2024
Significant events after Q3 2024Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loanOn October 10, The Board... ► Artikel lesen | |
ZICCUM Aktie jetzt für 0€ handeln | |||||
10.10.24 | Ziccum AB: Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loan | 114 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
30.08.24 | Ziccum AB: Ziccum AB (publ) Interim report Q2 2024 | 162 | GlobeNewswire (Europe) | INTERIM REPORT Q2, 1 JANUARY - 30 JUNE 2024
Significant events during Q2 2024Ziccum strengthens and streamlines business and finance functionsOn April 3, the company announced that it is reorganizing... ► Artikel lesen | |
29.04.24 | Ziccum AB: Ziccum AB (publ) Interim report Q1 2024 | 91 | GlobeNewswire (Europe) | INTERIM REPORT Q1, 1 JANUARY - 31 MARCH 2024
Significant events during the QuarterSuccessful outcomes of LaminarPace Feasibility study with Biotech partnerOn January 10, the company announced that,... ► Artikel lesen | |
06.03.24 | Nasdaq Stockholm AB: New equity right for trading, Ziccum AB TO5 (114/24) | 269 | GlobeNewswire | At the request of Ziccum AB, Ziccum AB equity rights will be traded on First
North Growth Market as from March 7, 2024.
Security name: Ziccum AB TO5
-----------------------------
Short name: ZICC... ► Artikel lesen | |
29.02.24 | Nasdaq Stockholm AB: Delising of paid subscription units of Ziccum AB from First North Growth Market (100/24) | 363 | GlobeNewswire | Last day of trading in paid subscription units (BTA) of Ziccum AB
Trading in Ziccum AB paid subscription units is to cease. The last trading day
is March 1, 2024.
Short name: ZICC BTU
---------------------------
ISIN... ► Artikel lesen | |
30.01.24 | Nasdaq Stockholm AB: Listing of unit rights and subscription units of Ziccum AB (44/24) | 370 | GlobeNewswire | With effect from January 31, 2024, the unit rights in Ziccum AB will be traded
on First North Growth Market. Trading will continue up until and including
February 09, 2024.
Instrument: Unit rights... ► Artikel lesen | |
26.01.24 | Ziccum AB: Year-End report Q4 2023 | 543 | GlobeNewswire (Europe) | YEAR-END REPORT Q4 2023: 1 JANUARY - 31 DECEMBER 2023
Significant events during the QuarterCollaboration agreement with University of CopenhagenOn December 4th, the company announced that it had signed... ► Artikel lesen | |
26.01.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 26.01.2024 | 710 | Xetra Newsboard | Das Instrument 4DX GB00BJTCG679 DX (GROUP) PLC LS -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 26.01.2024 und ex Kapitalmassnahme am 29.01.2024 The instrument 4DX GB00BJTCG679 DX (GROUP) PLC LS... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 36,350 | -0,08 % | Leichte Zugewinne bei der Fresenius SE & Co. KGaA-Aktie (36,58 €) | Das Wertpapier von Fresenius SE & Co. KGaA notiert heute fester. Der jüngste Kurs betrug 36,58 Euro. Die Fresenius+Co KgaA-Aktie verzeichnet gegenwärtig einen Wertanstieg von 2,75 Prozent. Sie hat sich... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 53,50 | +2,69 % | Siemens Healthineers: Dieser Trading-Tipp war ein Treffer ohne Gewinn! | Im Express-Service hatten wir eine Short-Trade vorgeschlagen und das war der Hinweis für Abonneten: "Charttechnisch betrachtet bewegt sich der Kurs seit Ende Juli in einer breiten Seitwärtsbewegung... ► Artikel lesen | |
THERMO FISHER | 534,80 | -0,04 % | MedMira mit zweiter Zulassung!: MedMira erhält von Health Canada Zulassung für Reveal® G4 Rapid HIV-1/2 Test | ||
EUROFINS SCIENTIFIC | 47,780 | -0,08 % | Eurofins Environment Testing Eaton Analytical Launches Groundbreaking Chloronitramide Anion Testing for Drinking Water | Eurofins Environment Testing Eaton Analytical, part of the Eurofins Environment Testing network of laboratories in the US and a leader in water quality analysis, has introduced a cutting-edge method... ► Artikel lesen | |
SYNLAB | 11,300 | 0,00 % | UNGLAUBLICHE Sondermeldung bei Synlab Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
DAVITA | 163,00 | +0,28 % | DaVita Earnings Preview: What to Expect | ||
DENTSPLY SIRONA | 18,070 | -0,11 % | Dentsply Sirona Plans To Redefine Byte Business Model | YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona (XRAY) said it plans to refocus the Byte business model around treatments that include expanded in-person dentist oversight. The company is evaluating... ► Artikel lesen | |
SMITH & NEPHEW | 12,280 | +0,45 % | Smith & Nephew UK Ltd: Smith+Nephew's ALLEVYN LIFE Sacrum Foam Dressing and LEAF Patient Monitoring System receive 'favorable' Evidence Bar ratings from ECRI for pressure injury prevention | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI - leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence... ► Artikel lesen | |
SONIC HEALTHCARE | 16,508 | +0,27 % | Dividendenbekanntmachungen (04.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEGON LTD BMG0112X1056 - 0,16 EUR AUTOLIV INC US0528001094 0,68 USD 0,6156 EUR AVERY DENNISON CORP US0536111091 0,88 USD 0,7967... ► Artikel lesen | |
DIASORIN | 102,90 | +1,03 % | Earnings call: DiaSorin reports growth and raises 2024 guidance | ||
PATTERSON COMPANIES | 30,200 | +1,34 % | XFRA PD2: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
FULGENT GENETICS | 16,500 | 0,00 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
IMPLANTICA | 3,180 | +0,79 % | Implantica announces new exceptional published data from the largest real-world study from Germany | VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device... ► Artikel lesen | |
PERSPECTIVE THERAPEUTICS | 3,000 | -9,64 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer | SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment... ► Artikel lesen | |
OMNICELL | 41,200 | 0,00 % | Omnicell Announces Third Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen |